Alexis Ohanian Says This Is His Best Investment So Far: $10,000 Turned Into More Than $17 Million Ivar AI

Ambcrypto.com

Crypto market cap surpasses France, UK GDPs – India, Japan next

Eldiario.es

Los vecinos de Siria toman posiciones tras la caída de Al Asad mientras los insurgentes empiezan a gobernar

Biztoc.com

Google Flexes Its Tech Muscles With Quantum Computing Chip, Waymo

Ambcrypto.com

Binance Coin [BNB] surges: 2 key reasons why

ZyCrypto

Shiro Neko Hits $1 Billion Market Cap on First Trading Day

Biztoc.com

Quantum Computing Stocks Roundup: D-Wave, Rigetti, IonQ Lead the Charge With Explosive Growth

BeInCrypto

Tether acuña $19 mil millones en USDT en un mes y genera debates en el mercado cripto

Noticiabrasil.net.br

Como a indústria automotiva da China pode afetar o mercado mundial de petróleo?

Www.abc.es

Las empresas constructoras españolas solidifican su sueño americano

Jornada.com.mx

Pactan el Mercosur y la UE acuerdo comercial histórico

BusinessLine

India may attract share of $36-trillion principal investor capital: BCG

Forbes

AI For Climate Change: A Range Of Ideas On Applications

BeInCrypto

La capitalización realizada de Ethereum registra máximo histórico y sugiere problemas para los bajistas de ETH

Eleconomista.es

Una nueva bajada de tipos por parte del BCE, la cuarta en el año, sobrevuela los mercados

Noticiaslatam.lat

¿Cómo la industria automotriz de China podría afectar al mercado mundial del petróleo?

DW (English)

Taiwan says China deploying largest naval fleet in decades

Financial Post

Hong Kong Stocks to Soar on China Stimulus Signals: Markets Wrap

GlobeNewswire

Cell and Gene Therapy Market is expected to reach a revenue of USD 111.4 Bn by 2033, at 19.3% CAGR: Dimension Market Research

$Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma$

GlobeNewswire

Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma